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Successful propargylamine drugs such as deprenyl inactivate monoamine oxidase
(MAO), a target in multi-faceted approaches to prevent neurodegeneration in the aging
population, but the chemical structure and mechanism of the irreversible inhibition are
still debated. We characterized the covalent cyanine structure linking the multi-target
propargylamine inhibitor ASS234 and the flavin adenine dinucleotide in MAO-A using
a combination of ultra-high performance liquid chromatography, spectroscopy, mass
spectrometry, and computational methods. The partial double bond character of the
cyanine chain gives rise to 4 interconverting geometric isomers of the adduct which were
chromatographically separated at low temperatures. The configuration of the cyanine
linker governs adduct stability with segments of much higher flexibility and rigidity
than previously hypothesized. The findings indicate the importance of intramolecular
electrostatic interactions in the MAO binding site and provide key information relevant
to incorporation of the propargyl moiety into novel multi-target drugs. Based on the
structure, we propose a mechanism of MAO inactivation applicable to all propargylamine
inhibitors.
Keywords: monoamine oxidase, propargylamine, inhibition mechanism, structure, electrostatic interactions,
quantum chemical calculations, isomers, interconversion
INTRODUCTION
Monoamine oxidases (MAO-A and MAO-B) catalyze the oxidative deamination of monoamine
neurotransmitters such as dopamine and serotonin (Weyler et al., 1990). The isoalloxazine ring
(Figure 1) of the covalently attached FAD moiety (1) is directly involved in the transformation of
primary, secondary, and tertiary amines into positively charged imines with concomitant reduction
of FAD to FADH−. Imines are afterwards non-enzymatically hydrolyzed to yield the corresponding
aldehyde and amine (Edmondson et al., 1993;Woo and Silverman, 1995). Despite much discussion,
the catalytic mechanism is still debated (Silverman et al., 1980; Silverman, 1995b; Miller and
Edmondson, 1999; Edmondson et al., 2004b, 2009; Li et al., 2006; Vianello et al., 2012; Akyüz and
Erdem, 2013; Orru et al., 2013; Pavlin et al., 2013; Chajkowski-Scarry and Rimoldi, 2014; Repicˇ
et al., 2014). The oxidation of the amine is also the first step of the irreversible inhibition pathway
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FIGURE 1 | Structure of isoalloxazine ring (1) and ASS234 propargylamine inhibitor (2).
by several types of inactivating compounds (Silverman, 1995a;
Kalgutkar et al., 2001; Chajkowski-Scarry and Rimoldi, 2014).
Although the inhibition of MAO by propargylamine derivatives
used in the treatment of neuropsychiatric and age-related
neurodegenerative disorders (Yu, 1994; Youdim et al., 2006)
dates to the late 1950s (Taylor et al., 1960), the structure of
irreversible propargylamine-inhibited MAO and the mechanism
of formation are still not fully understood (Edmondson et al.,
2009; Pavlin et al., 2013). Elucidating the details of the chemical
mechanism of MAO inactivation is key to rational design of new
generation drugs.
Plausible covalent adduct structures and inhibition
mechanisms of MAO by propargylamines were proposed
by Maycock et al. in 1975 (Maycock, 1975; Maycock et al.,
1976a,b). Proposed mechanisms without experimental evidence
included: (i) an enzymatic abstraction of the propargylic proton
from the inhibitor and its subsequent attack on oxidized FAD,
(ii) a mechanism proceeding through radical intermediates
which then collapse to form the cyanine adduct, (iii) a reduced
FADmoiety reacting with an oxidized inhibitor into the covalent
adduct. Later, in model reactions Nakai et al. employed truncated
analogs of isoalloxazine and (–)-deprenyl in quantum chemical
investigations (Nakai et al., 1999) to predict the formation of
two stable cyclic adducts (O4,N5- and C4a,N5-adduct) formed
through a series of intermediates and transition states. In a
computational study, Borštnar et al. proposed the deprotonated
acetylenic moiety of propargylamine as the reactive species to
attack the electrophilic N(5) of the oxidized flavin (Borštnar
et al., 2011), resulting in an adduct bearing an alkynyl moiety.
The inhibition mechanisms from these studies are inconclusive.
Furthermore, for the covalent binding of a propargylamine
inhibitor to MAO, adduct structures from different studies are
inconsistent (Gärtner et al., 1976; Nakai et al., 1999; Kalgutkar
et al., 2001; Binda et al., 2002, 2004; Edmondson et al., 2004b;
Hubálek et al., 2004; Borštnar et al., 2011; Pavlin et al., 2013;
Esteban et al., 2014).
ASS234 is a multi-target propargylamine compound that
inhibits both MAO and cholinesterases (Samadi et al., 2012).
It also has antioxidant capacity and prevents beta-amyloid
aggregation, making it a lead compound for Alzheimer’s disease
treatment (Marco-Contelles et al., 2016). Here we elucidate
the structure of the covalent adduct between MAO-A and the
multi-target propargylamine ASS234 (2) (Figure 1) by digesting
the inhibited enzyme to the flavopentapeptide (Nagy and
Salach, 1981), and separating and characterizing it by ultra
high-performance liquid chromatography coupled to photodiode
array and MS detectors (UHPLC-PDA-MS). Supported by
quantum chemical calculations and stopped-flow spectrometry,
we propose a general mechanism for MAO inactivation by
propargylamine drugs.
MATERIAL AND METHODS
The propargylamine inhibitor ASS234 was synthesized as before
(Samadi et al., 2012).
Inactivation of MAO-A With ASS234 and
Enzymatic Digestion
Recombinant human MAO-A was purified (Weyler and
Salach, 1985; Hynson et al., 2003) and dialyzed against
50mM HEPES pH 7.5 for 3 h. For the inactivation, MAO-
A (40µM) was incubated with ASS234 (200µM) at 30◦C
and monitored spectrophotometrically to completion [Shimadzu
2101PC (Kyoto, Japan) or PerkinElmer Lambda 45 (Waltham,
MA, USA)]. For digestion by trypsin/chymotrypsin (0.02mg
of each per mg of MAO protein), the solution was incubated
at 37◦C for 3 h. Another aliquot of trypsin/chymotrypsin was
added and incubated overnight. The digestion was quenched
by the addition of HCOOH and stored at −20◦C prior to
UHPLC-PDA-MSn analyses. The same procedure was followed
for the control sample without inhibitor and when MAO-A
was inhibited by clorgyline. Additional spectroscopic details are
provided in Supplementary Material.
For kinetics, MAO-A (40µM) was mixed with an equal
volume of 50mM HEPES pH 7.5 containing ASS234 (120µM)
in the stopped-flow spectrophotometer (Applied Photophysics
SX20) at 30◦C. Triplicate runs at three wavelengths (410, 456,
and 495 nm) were analyzed using single or double exponential
fits in the built-in software. Additional details are provided in
Supplementary Material.
UHPLC-PDA-MSn Analyses
The UHPLC system Accela 1250 with a PDA detector (Thermo
Finnigan, San Jose, CA, USA) was coupled to the LTQ Velos MS
system (Thermo Finnigan) equipped with a heated electrospray
ionization source (H-ESI). Xcalibur (2.1) software was used
for evaluation of the collected data. Further experimental and
instrument details are provided in Supplementary Material.
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Detection of Geometric Isomers With
Varying Temperature
The chromatographic and MS parameters were unaltered; only
the temperature was varied between −10, 10, 30, 45, 60 and
75◦C. The fractionation of 2 isomers was achieved at 10◦C by
injecting 25 µL of MAO-A-ASS234 digest solution (4µM) into
the column and collecting each individual peak separately at the
PDA exit. The process was repeated 5 times. The total volume
of both fractions was brought down to 50 µL and 25 µL of
each fraction was re-analyzed separately by UHPLC at 30◦C.
Additional experimental details are provided in Supplementary
Material.
Computational Methods
TheGibbs activation energy (1G‡) for the cis-trans isomerization
of the cyanine chain was determined from experimental
chromatographic data using transition state theory. The
interconversion energy barrier was calculated by the Eyring-
Polanyi equation describing the relation between the reaction
rate and the activation free energy:
k =
kBT
h
e−
1G‡
RT
where k = reaction rate constant, kB = Boltzmann constant, h =
Planck’s constant, T = temperature, and R = gas constant. The
1G‡ for the reaction at a given temperature is calculated from
the rate constant. Rate constants for the isomerization observed
in chromatograms at a particular temperature were determined
by DCXplorer software (Trapp, 2006). Rate constants and 1G‡
values were determined from the experimental chromatographic
data at 10 and 30◦C.
Quantum Chemical Calculations of Internal
Rotations of Cyanine Chain
The initial structure of the studied pentapeptide-FAD-ASS234
adduct was obtained by model building in Molden (Schaftenaar
and Noordik, 2000). A truncated model of the adduct was
used since the adenosine phosphoribosyl, pentapeptide moieties
from MAO-A and the cholinesterase inhibiting part of ASS234
were assumed to have no significant contribution on the
configuration of the cyanine chain. Initially unconstrained energy
minimization of the adduct was performed. Several starting
geometries were used in order to find the global minimum from
which we started internal rotation energy profile calculations by
the procedure as follows: four internal rotations were considered
and energy profiles were calculated by using a relaxed scan. The
starting geometry for each dihedral angle was the optimized
geometry of preceding dihedral value. Structures corresponding
to the profiles of internal rotations are formally conditional
minima with one fixed value of the dihedral angle with all
other degrees of freedom optimized. Therefore, rotation profiles
obtained by this procedure correspond to the minimum energy
path. Calculations were performed on the M06-2x/6-311+G
(d,p) level using the Gaussian 09 suite of programs (Frisch et al.,
2009). For energy minimization default values for convergence
criteria were used as built in Gaussian 09. Some values of dihedral
angles resulted in steric repulsion giving rise to very high energies
and the geometry optimization procedure was automatically
terminated.We did not report rotation profiles for those dihedral
angles values. Preliminary results indicated that solvent has only
minor effect on energy profiles and was therefore omitted in the
calculations.
RESULTS AND DISCUSSION
MAO-A-ASS234 Adduct Formation
Inactivation of MAO-A by the propargylamine ASS234 was
accompanied by changes in the UV-VIS spectrum (Figure 2A).
The absorption maximum at physiological conditions shifted
from 456 nm (oxidized FAD) to 410 nm in parallel with loss
of enzyme activity and formation of an adduct between MAO-
A and ASS234 (MAO-A-ASS234). When the adduct-containing
solution was acidified (pH 1) the absorption maximum shifted
toward 370 nm (Figure S1, Supplementary Material). This
hypsochromic shift confirms the N(5) adduct formation whereas
a bathochromic shift would indicate the C(4a) adduct (Ghisla
et al., 1973; Gärtner and Hemmerich, 1975).
The inactivation process was also monitored in the stopped-
flow spectrophotometer at three wavelengths: 456 nm—an
isosbestic point of the reaction in the steady-state; 495 nm—
a selective wavelength for flavin reduction (i.e., the enzyme
catalyzed reaction); and 410 nm—a wavelength for the adduct
formation. After rapid mixing of MAO-A and ASS234, there was
a small decrease in absorption at 456 nm before the isosbestic
point was established (Figure 2B). The rate of the initial decrease
at 495 nm shown in Figures 2B,C is 0.057 ± 0.006 s−1 (n = 3),
similar to the rate of the pre-steady-state change at 456 nm [k =
0.056 ± 0.006 s−1 (n = 3)]. At 410 nm where the adduct absorbs
strongly, a small decrease is observed initially, but the absorbance
starts to increase after 8 s with a 10-fold slower rate of 0.005 ±
0.006 s−1 (n = 3), similar to the steady-state rate of inactivation
(Esteban et al., 2014). This distinct lag before product is detected
is a pattern typical for the second reaction in a kinetic sequence,
indicating that FAD reduction precedes the formation of the
covalent adduct as has been observed previously for rasagiline
and its analogs (Hubálek et al., 2004).
MAO-A-ASS234 Adduct Pentapeptide
Characterization
In the UHPLC-DAD-MS analysis of the tryptic/chymotryptic
digest the uninhibited MAO-A gave a single sharp
chromatographic peak at 6.9min with strong absorbance at
450 nm (Figure S2) and an MS signal at m/z 1267 corresponding
to the [M–H]− of FAD-SGGCY pentapeptide (Figure S3).
Tandem MS spectrum, using a precursor ion at m/z 1267,
showed a strong fragment ion at m/z 920 (Figure S4) as a
result of adenosine monophosphate (AMP) cleavage from FAD-
pentapeptide. This neutral loss of 347 was used in subsequent
analyses as an identifier of FAD moiety.
The analysis of ASS234-inactivated MAO-A digest
(Figure 3A) gave a pair of peaks at 7.4 and 8.8min which
exhibited reduced absorbance at 450 nm. The absorption spectra
of these two peaks are identical, with λmax at 395 nm. The
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FIGURE 2 | ASS234 inhibition of MAO-A. (A) Spectra for MAO-A before and after ASS234 inactivation. (B) and (C) Absorbance changes for the first 40 s and 1000 s,
respectively, at 410, 456, and 495 nm after rapid mixing of equal volumes of MAO-A (40µM) and ASS234 (120µM) at 30◦C in a stopped-flow spectrophotometer.
FIGURE 3 | Geometric isomers of the flavin-ASS234 adduct from tryptic/chymotryptic digested MAO-A. (A) UHPLC chromatogram of ASS234-inhibited MAO-A
digest acquired at 410 nm (inset—extracted ion chromatogram at m/z 1710). (B) Temperature dependence of the interconversion rate for two geometric isomers. At
high temperatures isomers coalesce into a single chromatographic peak. (C) The extracted ion chromatogram at m/z 1710 obtained at −10◦C indicates the existence
of at least four isomers of the covalent adduct. A low abundant fourth isomer was detected as a shoulder on the major chromatographic peak (inset)—dashed line
simulates the expected shape of the major peak without co-elution.
absorption maximum for the peptide adduct is slightly blue-
shifted from the 410 nm observed in the intact MAO-A-ASS234
(physiological conditions) (Figure 2) due to mobile phase
solvent and pH effects. There is also a plateau between the
peaks, which is not observed in the uninhibited MAO-A digest.
Even though this pattern is not characteristic of fronting/tailing,
these and some other common chromatographic artifacts were
nevertheless systematically ruled out (Discussion S1), leaving
as its cause an intrinsic structural feature of the adduct after
inactivation of MAO-A by ASS234. TheMS spectra of both peaks
were identical and showed a signal at m/z 1710, corresponding
to the pentapeptide-FAD-ASS234 covalent adduct (Figure S5).
Moreover, the extracted ion chromatogram atm/z 1710 perfectly
overlapped with the 410 nm UV trace and showed the same
plateau between the two peaks (Figure 3A inset). Supporting
the presence of FAD moiety in the precursor ion at m/z 1710,
MS2 gave a fragment ion at m/z 1363, obtained by the neutral
loss of AMP (347 amu) (Figure S6). We hypothesized that
the two “bridged” peaks with exactly the same absorption
and mass spectra are geometric or conformational isomers.
Representations of some possible adduct structures are depicted
in Figure 4, with the underpinning reasoning and experimental
confirmation given below. An all-trans planar configuration
of the covalent linker between the enzyme and the inhibitor
(cyanine chain) was assumed at first, because the ground
state of such a system generally results in higher resonance
energy stabilization (Brooker et al., 1947; West et al., 1967).
Moreover, the cyanine chain bears no bulky substituents which
would cause steric hindrance and adaptation of an alternative
configuration.
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FIGURE 4 | Some examples of isomeric structures of the pentapeptide-FAD-ASS234 covalent adduct which can be formed by intramolecular rotations only about
C–N bonds (in red). Both positive charge delocalization extremes of the cyanine chain are depicted on the left hand side. The four possible geometric structures are
highlighted in the dashed square (intramolecular rotations about cyanine C–C bonds are not considered).
Conclusively, the observed signal for deprotonated adduct
molecule atm/z 1710 resolves the previous ambiguity of the form
of the reduced flavin in MAO-A (Edmondson et al., 2004a)—
it is the anionic form (FADH−). The pKa of N(1) in the flavin
peptide is substantially lower than in the native MAO-A as it
remains deprotonated even under our fairly acidic experimental
conditions (pH ≈ 2). MS data also prove the covalent bond
between MAO-A and ASS234 (see Discussion S2 for further
insight).
MAO-A-ASS234 Adduct Structure
Elucidation
The electronic structure of the adduct is complex, but it is
reasonable to speculate that the positive charge is delocalized
within the cyanine chain which has mixed single and double
bond character (Figure 4). Therefore, the conjugated scaffold
should be reflected in hindered rotation about both pairs of C–N
and C–C bonds. Internal rotations of such systems are generally
additionally disfavored because the resonance stabilization of the
positive charge is interrupted by the transition state between
the two forms and this should particularly be true for rotations
about C–C bonds in the middle of the cyanine chain. Our
assumption of a dynamic geometric isomerismwas demonstrated
by the experiment shown in Figure 3B. Two adduct forms
were separated chromatographically at 10◦C as two clearly
distinguished peaks because at this temperature the rate of cis-
trans isomerization was sufficiently low. Quantum-chemically
calculated energy profiles for internal rotations suggest that the
structure of the adduct is semi-flexible and associated with several
minima that are separated with the barriers of about 20 kcal/mol
(see below). As the temperature of the chromatographic analysis
increased, the two isomers interchanged more rapidly until, at
the highest temperature (75◦C), only one peak was detected. The
same phenomenon was observed when ASS234 was exchanged
for clorgyline, a standard propargylamine inactivator of MAO-
A, but the interconversion barrier was higher so that the isomers
were well separated even at higher temperatures (Figure S7).
Additional confirmation of the existence of interconverting
geometric isomers for the ASS234 adduct was obtained by
collecting the peaks at 10◦C as two individual fractions from
the UHPLC column outlet. The collected fractions were re-
analyzed by UHPLC, only to find that the adduct was again
seen as a mixture of two species in both cases (data not
shown). The “bridge” between peaks in Figure 3A can be ascribed
to the individual molecules which underwent at least one
interconversion cycle during the UHPLC experiment. Since the
cyanine chain consists of 2 non-equivalent pairs of C–N and
C–C bonds (Figure 4) there are 16 (24) hypothetically viable
geometric isomers if we allow deviations from a theoretically
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more stable all-trans configuration. However, not all, but only
isomers with a low enough molecular potential energy (stable
isomers) can actually be detected. By significantly lowering the
temperature in the chromatographic experiment (to−10◦C), two
additional species were experimentally confirmed (Figure 3C),
which indirectly demonstrates the existence of the cyanine chain
in the adduct. Due to its low abundance, the fourth isomer was
detected merely as a shoulder of the main peak (Figure 3C—
inset). Chromatographic tailing could be ruled out as a probable
cause of this observation since tailing peaks do not contain an
inflection point (shoulder) unless there is co-elution of one or
more compounds. We were unable to detect any further isomers
because use of temperatures lower than−10◦C in the experiment
was not possible.
The isomerization rate constants at two temperatures
(10◦C, 30◦C) were determined from our raw experimental
chromatographic data using DCXplorer software [based on the
unified equation of chromatography (Trapp, 2006)]. Then, the
interconversion energy barrier (1G‡) for the two isomers clearly
separated at 10◦C was calculated by employing the transition
state theory (Eyring-Polanyi equation). The rate constant at 10◦C
was 2.1 × 10−4 s−1 yielding 1G‡ = 21.3 kcal/mol. At 30◦C
the rate constant increased to 2.0 × 10−3 s−1 corresponding
to 1G‡ = 21.5 kcal/mol. With clorgyline at 30◦C, a lower rate
constant was obtained (3.9× 10−4 s−1) and the activation energy
proportionately higher (1G‡ = 23.6 kcal/mol). The overall
activation energies (1G‡ ≈22 kcal/mol) for the isomerization
in these adducts are similar to rotation energy barriers for C–N
amide bonds possessing partial double-bond character.
To define which interconversions give the observed cis-
trans isomerism, quantum chemical calculations of cyanine
internal rotations were performed using a truncated model
of the pentapeptide-FAD-ASS234 covalent adduct (Figure 5A).
The energy profiles for the four dihedral angles D1–D4 in the
cyanine chain were calculated (Figure 5B) and compared to our
chromatographic experimental data obtained at 10◦C. According
to the D1 internal rotation energy profile (Figure 5B, D1) it is
very unlikely that this rotation is responsible for the doubled
peaks in the chromatogram. However, the system is at a low
energy state at θ = 0◦ where the cyanine structural element is
co-planar and in close proximity to the pyrimidinedione ring
of isoalloxazine moiety. This indicates that the steric hindrance
FIGURE 5 | Energy profiles of internal rotations in the truncated model of the pentapeptide-FAD-ASS234 adduct. (A) The four dihedral angles are defined in blue (D1),
green (D2), red (D3), and orange (D4). (B) Energy profiles of internal rotations around dihedral angles D1, D2, D3, and D4. Relaxed scans were performed on the
M062x/6-311+G(d,p) level of theory.
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FIGURE 6 | A 3D structural representation of energetically most stable geometric adduct structure which has the largest contribution to the overall compound
configuration. (A) Free truncated adduct. (B) Adduct inside the active site of MAO A.
imparted by the carbonyl oxygen is compensated by the mutual
electrostatic stabilization of the positive charge (cyanine chain)
and negative charge (pyrimidinedione ring in FADH−); other
flavoprotein oxidases, but not MAO, have a positively charged
amino acid near N(1) to stabilize the anionic hydroquinone
(Ghisla and Massey, 1986; Edmondson et al., 2004a). An energy
increase at θ ≈ 90◦ is indicative of the disruption of conjugation,
but as the dihedral angle approaches 180◦ and the positive
charge moves further away from the pyrimidinedione ring, the
electrostatic stabilization weakens, evidenced by an unfavorable
and substantial increase in energy (>70 kcal/mol). Dihedral
angles of >180◦ also resulted in steric repulsion, giving rise
to very high energies and, thus, the geometry optimization
procedure was automatically terminated at this point.
The energy profile for D2 (Figure 5B, D2) shows asymmetry
of 2.5 kcal/mol, which is in a relatively good accordance with the
experimental value of 1 kcal/mol, but energy barriers of 11.9 and
17.8 kcal/mol should produce a single peak in the chromatogram
at 10◦C as a result of rapid interconversion between isomers.
Considering the D2 rotation further, the system is most stable
at θ = 0◦, which puts the ASS234 nitrogen in the cyanine chain
in close proximity to the pyrimidinedione ring. This prevents
the localization of the positive charge on the N(5) nitrogen and
enables optimum electrostatic and resonance energy stabilization
of the adduct. Nonetheless, the energy difference of the system at
θ = 0◦ and θ ≈ 180◦ is negligible compared to the D1 rotation.
The activation energies (26.8–26.9 kcal/mol) for the internal
rotation around D3 (Figure 5B, D3) are too high to explain the
phenomena in the chromatograms, but the large asymmetry of
5.3 kcal/mol indicates that the system clearly favors the ASS234
tail turned away from the FAD at θ ≈ 180◦.
Finally, the barrier of 22.5 kcal/mol shown in the profile of D4
(Figure 5B, D4) and the energy asymmetry of 1.2 kcal/mol are in
excellent agreement with the experimentally determined values of
21.3 kcal/mol (DCXplorer) and 1 kcal/mol, respectively. Profile
D4 is further discussed in Discussion S3. These results indicate
that geometric isomerization about this C–N bond (D4 internal
rotation) is most likely responsible for the two isomers observed
in the chromatogram at 10◦C, while the second pair of peaks
appearing at −10◦C could be attributable to isomerization about
the C–C bond (D2). Relative ease of rotation around D2 and
D4 in comparison to D1 and D3 also suggests that the positive
charge is not as evenly delocalized in the cyanine chain as initially
suspected, but is preferentially concentrated at N(5) due to the
strong electrostatic stabilizing effect. What is more, these energy
profiles indicate that the electrostatic stabilization of the adduct
is far greater than stabilization through charge delocalization.
These quantum chemical calculations considered each
internal rotation individually in order to obtain energy profiles.
However, when a minimum potential energy of truncated adduct
was calculated by full geometry optimization in four-dimensional
space (starting from the above optimal values of dihedral angles,
D1 = 0◦, D2 = 350◦, D3 = 180◦, and D4 = 150◦), slightly
different cyanine chain dihedral angles were obtained (D1 =
312◦, D2 = 353◦, D3 = 183◦, and D4 = 94◦). The general
molecule configuration stays relatively preserved and the cyanine
chain is slightly coiled. This puts the cyanine CH2 group (next
to the tail end tertiary amine) below the bent plane of the
isoalloxazine ring, thus, avoiding any steric hindrance with the
carbonyl group of the pyrimidinedione ring (Figure 6A). The
O . . . C distance of 2.8 A implies a slight attraction which could
be attributed to a CH . . . O quasi-hydrogen bond or electrostatic
attraction of the positively charged cyanine chain and negatively
charged pyrimidinedione ring. The four consecutive C–N and
C–C bond lengths in the chain, starting from the N(5) atom
of the flavin, are 1.32, 1.40, 1.38, and 1.33 Å. These support
a partial double bond character and at the same time give an
additional evidence of an unequal delocalization of the positive
charge, which is slightly more concentrated at the N(5) end of
the cyanine chain.
Based on the results from the experiments and the quantum
chemical calculations, the most stable structure for the FAD-
containing pentapeptide-ASS234 covalent adduct is that shown
in Figure 6A. Configuration of the C–N(5) bond is rigid,
extending outwards below the plane of themiddle flavin ring with
the cyanine chain bent toward the electron rich pyrimidinedione
ring. Although the rest of the conjugated chain has a higher
degree of flexibility, a quasi-planar cyanine chain configuration is
favored because it enables resonance stabilization of the positive
charge. The cyanine chain breaks from the all-trans configuration
and reorients to maximize electrostatic stabilization with the
pyrimidinedione ring. Although the complexity of the adduct can
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certainly not be captured with a single structural representation,
we conclude that this geometric structure has the largest
contribution to the overall compound configuration.
However, docking the truncated adduct into the MAO A
active site revealed that the ideal adduct structure cannot be
developed in the active site. Here, the environment of the enzyme
does not support a coiled cyanine structure and instead, a
more extended chain is demonstrated to be most energetically
favorable (Figure 6B). However, the charged chain remains bent
toward pyrimidinedione ring which again demonstrates the
significance of stabilization by attraction of opposite charges.
This configuration of a quasi-all-trans conjugated chain is in
good accordance with the electron density in the crystal structure
of the intact MAO B-ASS234 adduct reported by Esteban et al.
(2014). Their X-ray data revealed the position of the inhibitor
inside the active site but at 1.8 Å resolution did not necessarily
provide enough information to deduce the detailed structure
of the adduct. The structure and data in our study allow
for quantum chemical calculations. The resulting structure is
consistent with the abovementioned electron density map but
provides more detail (such as position of hydrogen atoms and
saturation degree of aliphatic linker) and is more relevant to
the enzyme in the cell rather than in a fixed crystal. A neutral
pyrimidinedione ring and the lack of a cyanine moiety in the
adduct structure proposed by Esteban et al. does not allow for
isomerism observed in our study because rotations about single
bond or double bonds in the adduct linker are believed to be
unhindered or energetically extremely unfavorable, respectively.
Our study also confirms that the whole ASS234 is attached to
FAD as was implied by the intact mass but not visible in the
crystal (Esteban et al., 2014).
Chemical Mechanism of MAO-A
Irreversible Inhibition by ASS234
Based on the results of this study, we propose a new chemical
mechanism for MAO-A inactivation by ASS234 that is consistent
with all published experimental data (Figure 7). This pathway
could be extended to both MAO enzymes and propargylamine
inhibitors in general.
The propargylamine inhibitors (2) are substrate analogs that
can be processed by the targeted enzyme to generate highly
reactive species which in turn covalently modify the enzyme and
suppress its catalytic activity (Silverman, 1995a; Szewczuk et al.,
2007). The first step is ASS234 oxidation by MAO giving the
iminium cation (represented here by two resonance forms 3a
and 3b) and FADH− (see further reasoning in Discussion S4).
The mechanistic pathway of this reaction has been extensively
reviewed (Chajkowski-Scarry and Rimoldi, 2014). Although the
imine is highly reactive, hydrolysis measured for a MAO–B
imine product is slower than catalytic turnover indicating that
hydrolysis to aldehyde happens in the solvent after dissociation
(Edmondson et al., 1993; Woo and Silverman, 1995).
One important question arises. Why do oxidized substrate
amines leave the enzyme as oxidation products but these
inactivators do not? It has been shown that positively charged
molecules can be trapped by favorable cation-pi interactions
in the active site “aromatic cage” formed by aromatic amino
acid residues Tyr406 and Tyr444, and the isoalloxazine ring
(Borštnar et al., 2012). Our results show that the attraction
between a positively charged species and negatively charged
pyrimidinedione ring also presents a considerable electrostatic
force. Therefore, prior to dissociation the charged oxidized
substrates are deprotonated in a concerted reaction involving
nearby water molecules (Vianello et al., 2012). On the other hand,
many well-known tertiary amino substrates such as MPTP and
hordenine (N,N-dimethyltyramine) are poor MAO substrates.
MAO oxidation products of these species are also represented by
charged imines, but these bear no hydrogens on the quaternary
nitrogen atom. The deprotonation and therefore neutralization
cannot occur and the disengagement of these molecules from
MAO active site is hindered due to the strong electrostatic forces.
ASS234 and the other propargylamines also belong to the group
of tertiary amines. Oxidation of C–N bond in the beta position to
the alkynyl functional group in ASS234, gives a charged species
(3a,3b) which is unable to dissociate from MAO-A active site.
Our reasoning is supported by a previous study which showed
that methylation of the amino group significantly increased the
activity of a propargylamine inhibitor whereas species containing
-NH- were less efficacious (Kalir et al., 1981). The subsequent
nucleophilic attack of FADH− is thermodynamically driven as
the adduct structure clearly demonstrates the allenyl resonance
form (3b) as being involved in the reaction (see Discussion
S5 for further explanation). The kinetic product proceeding via
nucleophilic attack of FADH− on the ASS234 carbon in the
alpha position to the alkynyl functional group (3a) would be
represented by a highly branched compound suffering from
severe steric hindrance and would lack the observed UV-VIS
distinctive chromophore at λmax = 410 nm. The outcome of the
nucleophilic addition is a substituted 1,3-diaminoallene (4). This
allene undergoes a rapid 1,3-prototropic rearrangement, as was
shown for similar systems (Maas and Mayer, 1991; Espenlaub
et al., 2007). The reaction is assumed to be mediated by a
nearby water molecule which indirectly transfers the proton
from N(5) nitrogen to the sp hybridized allenyl carbon atom,
which eventually yields (5). Consequently, the positive charge
can be delocalized along the newly formed cyanine chain that
preferentially adopts a coiled conformation to allow maximum
electrostatic stabilization.
CONCLUSIONS
MAO-A unambiguously forms a covalent adduct with the
propargylamine inhibitor ASS234. The bond between the two
species was shown here to comprise of a cyanine linker. This
electron deficient moiety has a double bond character which gives
rise to an intricate structural equilibrium of the adduct, resulting
in geometric isomerism of the inactivated flavopentapeptide.
The most stable coiled isomer of the adduct revealed that
the intramolecular electrostatic interactions are of paramount
importance in terms of compound stability. Additionally, the
flexibility of the inhibitor to adopt different configurations is
important as it prevents steric hindrances between the positively
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FIGURE 7 | Proposed mechanism of irreversible MAO inhibition by propargylamines.
charged cyanine linker and the electron rich pyrimidinedione
ring of FAD and finally, between ASS234 and the immediate
surroundings in the MAO-A active site when the whole system is
considered. The mutual electrostatic attraction of two opposing
charges seen here has important implications for the catalytic
mechanism of MAO in that oxidized charged substrates are
not likely to dissociate from the enzyme active site until they
are deprotonated or the pyrimidinedione ring is neutralized.
In addition, the anionic hydroquinone, detected here in the
final adduct, might have a bigger role in inactivation and
catalysis than previously recognized. Delocalized electronic
density which spreads over the entire pyrimidinedione ring in
reduced MAO could facilitate (re)orientation of charged and
polarizable products. Further experiments, which are outside of
the scope of this study, are needed to confirm these hypotheses.
Based on the results presented here, and in correlation with
published experimental data, the full inhibition mechanism
of MAO-A by propargylamines is proposed. The mechanism
described here is important both from theoretical and practical
standpoints. As well as a relevant foundation for mechanistic
studies of other flavoenzymes, our findings present information
for the rational design of efficient new generation drugs for the
treatment of neurodegenerative and neuropsychiatric disorders.
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